AADI logo

AADI

Profile

Full Name

Whitehawk Therapeutics, Inc.

Ticker Symbol

NASDAQ: AADI

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 16, 2018

Indexes

Not included

Website

http://aadibio.com

Employees

53

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$25.98M(+6.69% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    -
    AADI price value is unknown

    30-Day Relative Volume

    -
    AADI 30-day relative volume value is unknown

    Price Performance

    Price Most recent change

    -
    AADI price change on Jan 1, 1 is unknown

    Price YTD change

    -
    AADI price ytd change is unknown

    Price 1-year change

    -
    AADI price 1-year change is unknown

    Price 3-year change

    -
    AADI price 3-year change is unknown

    Price Range

    Price All-time high

    $78.00
    AADI price is currently at an all-time high

    Price 3-year low

    $1.21
    AADI price is currently at its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    -
    AADI market capitalization value is unknown

    Market cap 3-year change

    -
    AADI market capitalization 3-year change is unknown

    Market cap All-time high

    $681.59M
    AADI market capitalization is currently at an all-time high

    Market cap sector rank

    -
    AADI market capitalization is unknown

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.13%
    AADI shares outstanding is up +0.13% year-on-year

    Shares Outstanding 3-Year Change

    +17.27%
    AADI shares outstanding is up +17.27% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -
    AADI beta value is unknown

    200-day SMA

    -
    AADI SMA 200 is unknown

    50-day SMA

    -
    AADI SMA 50 is unknown

    RSI

    -
    AADI 14-day relative strength index value is unknown

    Volume

    -
    AADI 30-day relative volume value is unknown

    ATR

    -
    AADI average true range value is unknown

    10-day Historical Volatility

    -
    AADI 10-day historical volatility value is unknown

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $25.98M
    AADI annual revenue is $25.98 million

    Revenue Analysts estimate

    $50.00M
    AADI annual revenue is currently -48.03% lower than the consensus analysts' forecast

    Revenue 1-year change

    +6.69%
    AADI annual revenue is up +6.69% year-on-year

    Revenue Sector rank

    -
    AADI annual revenue is unknown

    EPS

    EPS

    -
    AADI annual earnings per share value is unknown

    EPS Analysts estimate

    -
    AADI annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    -
    AADI annual earnings per share 1-year change is unknown

    EPS Sector rank

    -
    AADI annual earnings per share is unknown

    Profit

    Gross profit

    $22.96M
    AADI annual gross profit is $22.96 million

    Gross margin

    88.36%
    AADI annual gross profit margin is 88.36%

    Operating profit

    -$64.82M
    AADI annual operating income is -$64.82 million

    Operating margin

    -249.47%
    AADI annual operating profit margin is -249.47%

    Net income

    -$63.69M
    AADI annual net profit is -$63.69 million

    Net margin

    -
    AADI annual net profit margin value is unknown

    Expenses

    Total expenses

    $90.80M
    AADI annual total expenses is $90.80 million

    Operating expenses

    $87.78M
    AADI annual total operating expenses is $87.78 million

    Cost of goods sold

    $3.02M
    AADI annual cost of goods sold is $3.02 million

    Selling, general & administrative expenses

    $36.75M
    AADI annual SGA is $36.75 million

    Depreciation and amortization

    $193.00K
    AADI annual depreciation & amortization is $193.00 thousand

    Interest expense

    $154.00K
    AADI annual interest expense is $154.00 thousand

    Income tax

    $0.00
    AADI annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$63.54M
    AADI annual earnings before interest & taxes is -$63.54 million

    EBITDA

    -$60.70M
    AADI annual EBITDA is -$60.70 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $70.32M
    AADI annual total assets is $70.32 million

    Non current assets

    $9.03M
    AADI annual long term assets is $9.03 million

    Current assets

    $61.29M
    AADI annual total current assets is $61.29 million

    Cash and cash equivalents

    $28.67M
    AADI annual cash & cash equivalents is $28.67 million

    Accounts receivable

    $5.90M
    AADI annual accounts receivable is $5.90 million

    Inventory

    $5.31M
    AADI annual inventory is $5.31 million

    Liabilities

    Total liabilities

    $17.84M
    AADI annual total liabilities is $17.84 million

    Long term liabilities

    $767.00K
    AADI annual total long term liabilities is $767.00 thousand

    Current liabilities

    $17.07M
    AADI annual total current liabilities is $17.07 million

    Accounts payable

    $2.16M
    AADI annual accounts payable is $2.16 million

    Debt

    Total debt

    $833.00K
    AADI annual total debt is $833.00 thousand

    Total debt 1-year change

    -34.25%
    AADI annual total debt is down -34.25% year-on-year

    Long term debt

    $565.00K
    AADI annual long term debt is $565.00 thousand

    Short term debt

    -
    AADI annual short term debt value is unknown

    Equity & Capital

    Shareholders equity

    $52.48M
    AADI annual stockholders equity is $52.48 million

    Book value

    $52.48M
    AADI annual book value is $52.48 million

    Retained earnings

    -$332.65M
    AADI annual retained earnings is -$332.65 million

    Working capital

    $44.21M
    AADI annual working capital is $44.21 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$59.55M
    AADI annual cash flow from operations is -$59.55 million

    Cash from operations 1-year change

    +0.19%
    AADI annual cash flow from operations is up +0.19% year-on-year

    Cash from investing

    $25.20M
    AADI annual cash flow from investing activities is $25.20 million

    Cash from investing 1-year change

    -69.71%
    AADI annual cash flow from investing activities is down -69.71% year-on-year

    Cash from financing

    $130.00K
    AADI annual cash flow from financing activities is $130.00 thousand

    Cash from financing 1-year change

    -60.12%
    AADI annual cash flow from financing activities is down -60.12% year-on-year

    CAPEX

    CAPEX

    $1.65M
    AADI annual capital expenditures is $1.65 million

    CAPEX 1-year change

    -58.36%
    AADI annual capital expenditures is down -58.36% year-on-year

    Free Cash Flow

    Free cash flow

    -$61.20M
    AADI annual free cash flow is -$61.20 million

    Free cash flow 1-year change

    +3.82%
    AADI annual free cash flow is up +3.82% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    88.36%
    AADI annual gross profit margin is 88.36%

    Operating margin

    -249.47%
    AADI annual operating profit margin is -249.47%

    Net margin

    -
    AADI annual net profit margin value is unknown

    ROA & ROE

    ROA

    -90.57%
    AADI annual return on assets is -90.57%

    ROE

    -121.37%
    AADI annual return on equity is -121.37%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    AADI price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    AADI price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -
    AADI price to book ratio value is unknown

    PB ratio Sector rank

    -
    AADI price to book ratio is unknown

    PS Ratio

    PS ratio

    -
    AADI price to sales ratio value is unknown

    PS ratio Sector rank

    -
    AADI price to sales ratio is unknown

    Enterprise value

    Enterprise value

    -
    AADI enterprise value value is unknown

    Enterprise value Sector rank

    -
    AADI enterprise value is unknown

    EV/EBITDA

    EV/EBITDA

    -
    AADI EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    AADI EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.59
    AADI annual current ratio is 3.59

    Quick ratio

    3.28
    AADI annual quick ratio is 3.28

    Leverage

    Debt to equity

    0.02
    AADI annual debt to equity ratio is 0.02

    Interest coverage ratio

    -412.58
    AADI annual interest coverage ratio is -412.58

    Risk & Stability

    Piotroski F-Score

    6
    AADI piotroski f-score is 6

    Altman Z-Score

    -
    AADI altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    Aug 27, 24 Piper Sandler
    Neutral
    Aug 21, 24 TD Cowen
    Hold
    Aug 21, 24 HC Wainwright & Co.
    Neutral
    May 14, 24 HC Wainwright & Co.
    Neutral
    Dec 15, 23 Piper Sandler
    Overweight
    Dec 15, 23 HC Wainwright & Co.
    Neutral
    Nov 13, 23 HC Wainwright & Co.
    Buy
    Aug 10, 23 HC Wainwright & Co.
    Buy
    Jun 8, 23 HC Wainwright & Co.
    Buy
    May 17, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with AADI included

    No data
    • What is the ticker symbol for Whitehawk Therapeutics, Inc.?
    • Does Whitehawk Therapeutics, Inc. pay dividends?
    • What sector is Whitehawk Therapeutics, Inc. in?
    • What industry is Whitehawk Therapeutics, Inc. in?
    • What country is Whitehawk Therapeutics, Inc. based in?
    • When did Whitehawk Therapeutics, Inc. go public?
    • Is Whitehawk Therapeutics, Inc. in the S&P 500?
    • Is Whitehawk Therapeutics, Inc. in the NASDAQ 100?
    • Is Whitehawk Therapeutics, Inc. in the Dow Jones?
    • When was Whitehawk Therapeutics, Inc.'s last earnings report?
    • When does Whitehawk Therapeutics, Inc. report earnings?

    What is the ticker symbol for Whitehawk Therapeutics, Inc.?

    The ticker symbol for Whitehawk Therapeutics, Inc. is NASDAQ:AADI

    Does Whitehawk Therapeutics, Inc. pay dividends?

    No, Whitehawk Therapeutics, Inc. does not pay dividends

    What sector is Whitehawk Therapeutics, Inc. in?

    Whitehawk Therapeutics, Inc. is in the Healthcare sector

    What industry is Whitehawk Therapeutics, Inc. in?

    Whitehawk Therapeutics, Inc. is in the Biotechnology industry

    What country is Whitehawk Therapeutics, Inc. based in?

    Whitehawk Therapeutics, Inc. is headquartered in United States

    When did Whitehawk Therapeutics, Inc. go public?

    Whitehawk Therapeutics, Inc.'s initial public offering (IPO) was on February 16, 2018

    Is Whitehawk Therapeutics, Inc. in the S&P 500?

    No, Whitehawk Therapeutics, Inc. is not included in the S&P 500 index

    Is Whitehawk Therapeutics, Inc. in the NASDAQ 100?

    No, Whitehawk Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Whitehawk Therapeutics, Inc. in the Dow Jones?

    No, Whitehawk Therapeutics, Inc. is not included in the Dow Jones index

    When was Whitehawk Therapeutics, Inc.'s last earnings report?

    Whitehawk Therapeutics, Inc.'s most recent earnings report was on March 20, 2025

    When does Whitehawk Therapeutics, Inc. report earnings?

    The date for Whitehawk Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page